NCT06725355View on ClinicalTrials.gov

To Compare the Pharmacokinetics and Safety After a Single Dose Administration of IN-G00002 and IN-R00002 in Healthy Adult Volunteers

PHASE1Active, not recruitingINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

August 16, 2024

Primary Completion Date

October 8, 2024

Study Completion Date

January 14, 2025

Conditions
Non-valvular Atrial Fibrillation (NVAF)
Interventions
DRUG

IN-R00002

Single administration of IN-R00002 60mg

DRUG

IN-G00002

Single administration of IN-G00002 60mg

Trial Locations (1)

Unknown

Central Hospital, Clinical Trial Center, Siheung

Sponsors
All Listed Sponsors
lead

HK inno.N Corporation

INDUSTRY

NCT06725355 - To Compare the Pharmacokinetics and Safety After a Single Dose Administration of IN-G00002 and IN-R00002 in Healthy Adult Volunteers | Biotech Hunter | Biotech Hunter